4
Changes in Ownership
Anixa Biosciences Inc Filed Acc 0001493152-22-026121
Chief Executive Officer gave up 491,900 shares (to pay taxes)
- Chief Executive Officer acquired 640,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KUMAR AMIT Chief Executive Officer | 2022-09-15 | Option exercise | +640,000 | $2.58 | $1,648,000 | 954,000 | D |
| KUMAR AMIT Chief Executive Officer | 2022-09-15 | Shares withheld for taxes | −491,900 | $4.48 | $2,203,712 | 462,100 | D |
| Derivatives | |||||||
| KUMAR AMIT Chief Executive Officer | 2022-09-15 | Option exercise · Employee Stock Option (Right to Buy) | −640,000 | 0 | D | ||
Loading xslF345X03/ownership.xml…